Physician profile
Jose E Torres
NPI 1437368404
$5,877.04
in general payments reported to CMS, 2019-2025
32 companies · $161 in 2025
The $161 reported for 2025 was less than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,190 · 2020: $396 · 2021: $260 · 2022: $334 · 2023: $182 · 2024: $353 · 2025: $161.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $696.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $696.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $1,614.04 | 2019 | |
| Covidien Lp | $1,373.96 | 2019-2020 | |
| Edwards Lifesciences Corporation | $1,108.05 | 2019-2025 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Atricure, INC. | $430.45 | 2020-2022 | |
| Novartis Pharmaceuticals Corporation | $181.44 | 2023-2025 | |
| Getinge USA Sales, LLC | $138.38 | 2022-2023 | Vasoview Hemopro 2 |
| Medtronic, INC. | $95.85 | 2022 | |
| Abbott Laboratories | $92.00 | 2019-2024 | Jot Dx |
| Livanova USA, INC. | $87.24 | 2019 | |
| Haemonetics Corporation | $79.29 | 2019-2024 | Teg6s Hemostasis System |
| Janssen Pharmaceuticals, INC | $66.08 | 2019-2024 | Xarelto |
| Intuitive Surgical, INC. | $51.25 | 2020-2021 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $51.18 | 2021-2025 | Lifevest |
| Boehringer Ingelheim Pharmaceuticals, INC. | $46.36 | 2024 | Jardiance |
| Boston Scientific Corporation | $43.70 | 2019-2025 | Watchman Access System |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $40.67 | 2019-2021 | |
| Esperion Therapeutics, INC. | $39.10 | 2025 | Nexletol |
| Baxter Healthcare | $36.73 | 2023-2024 | Perclot, Preveleak |
| Biomerieux INC | $32.60 | 2024 | Vidas Nephrocheck |
| Stryker Corporation | $31.57 | 2023 | 1688 |
| Pfizer INC. | $30.60 | 2023 | |
| Becton, Dickinson and Company | $26.26 | 2019 | |
| Abiomed | $23.25 | 2021 | |
| Lemaitre Vascular, INC. | $21.75 | 2023 | Tyke, Patch, Pledget and Intracardiac |
| Kiniksa Pharmaceuticals International, Plc | $21.17 | 2024 | Arcalyst |
| Medistim USA, INC. | $20.74 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $18.21 | 2024 | Eliquis |
| Bayer Healthcare Pharmaceuticals INC. | $18.05 | 2023 | |
| Ethicon US, LLC | $16.95 | 2021 | |
| Zimmer Biomet Holdings, INC. | $14.68 | 2025 | Sternalock |
| Astrazeneca Pharmaceuticals Lp | $13.51 | 2024 | Andexxa |
| Chiesi USA, INC. | $11.93 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jose Torres listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.